UM  > 中華醫藥研究院
Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s)
Hu H.2; Chung C.-C.1
2015
Source PublicationInternational Journal of Health Policy and Management
ISSN23225939
Volume4Issue:12Pages:823-829
Abstract

Background: This article sets up the initial discussion of the evolution of biopharmaceutical innovation in China through the perspective of sectoral innovation system (SIS). Methods: Two data sources including archival documentary data and field interviews were used in this study. Archival documentary data was collected from China Food and Drug Administration (CFDA) and Chinese National Knowledge Infrastructure (CNKI). In addition, industrial practitioners and leading researchers in academia were interviewed. Results: Biopharmaceutical in China was established through international knowledge transfer. The firms played more active role in commercializing biopharmaceutical in China though universities and research institutes were starting to interact with local firms and make contribution to biopharmaceutical industrialization. The transition of the Chinese government’s policies continuously shapes the evolution of biopharmaceutical sector. Policies have been dramatic changes before and after 1980s to encourage developing biopharmaceutical as a competitive industry for China. Conclusion: A SIS for biopharmaceutical has been shaped in China. However, currently biopharmaceutical is still a small sector in China, and for the further growth of the industry more synthetic policies should be implemented. Not only the policy supports towards the research and innovation of biopharmaceuticals in the early stage of development should be attended, but also commercialization of biopharmaceutical products in the later stage of sales.

KeywordBiopharmaceutical Biotechnology China Pharmaceutical Industry Sectoral Innovation System (Sis)
DOI10.15171/ijhpm.2015.162
URLView the original
Indexed BySCI
Language英语
WOS Research AreaHealth Care Sciences & Services
WOS SubjectHealth Care Sciences & Services ; Health Policy & Services
WOS IDWOS:000379814100005
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorChung C.-C.
Affiliation1.National Cheng Kung University
2.Universidade de Macau
Recommended Citation
GB/T 7714
Hu H.,Chung C.-C.. Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s)[J]. International Journal of Health Policy and Management,2015,4(12):823-829.
APA Hu H.,&Chung C.-C..(2015).Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s).International Journal of Health Policy and Management,4(12),823-829.
MLA Hu H.,et al."Biopharmaceutical innovation system in China: System evolution and policy transitions (pre-1990s-2010s)".International Journal of Health Policy and Management 4.12(2015):823-829.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Hu H.]'s Articles
[Chung C.-C.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Hu H.]'s Articles
[Chung C.-C.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Hu H.]'s Articles
[Chung C.-C.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.